Genetic association studies of antioxidant pathway genes and schizophrenia
- PMID: 20673164
- PMCID: PMC3159115
- DOI: 10.1089/ars.2010.3508
Genetic association studies of antioxidant pathway genes and schizophrenia
Abstract
The endogenous production of highly reactive oxidation species is an inherent by-product of cellular energy metabolism. Cellular antioxidant defense systems (AODS) comprising various antioxidants counter these damaging effects. Several lines of evidence, including postmortem studies, suggest increased oxidative stress in patients with schizophrenia. Some genetic association studies and gene-expression studies suggest that patients also may have altered ability to mount antioxidative mechanisms. As the genetic associations may provide etiologic evidence in support of the oxidative-stress hypothesis of schizophrenia, a focused review has been conducted. We also suggest avenues for further research.
References
-
- Akyol O. Yanik M. Elyas H. Namli M. Canatan H. Akin H. Yuce H. Yilmaz HR. Tutkun H. Sogut S. Herken H. Ozyurt H. Savas HA. Zoroglu SS. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:123–131. - PubMed
-
- Al-Chalabi A. Almasy L. Genetics of Complex Human Diseases: a Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 2009.
-
- Butticaz C. Werge T. Beckmann JS. Cuenod M. Do KQ. Rivolta C. Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia. Psychiatr Genet. 2009;19:201–208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous